Clinical Trials Logo

Nasopharyngeal Carcinoma (NPC) clinical trials

View clinical trials related to Nasopharyngeal Carcinoma (NPC).

Filter by:
  • None
  • Page 1

NCT ID: NCT04215978 Active, not recruiting - Clinical trials for Non Small Cell Lung Cancer

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Start date: January 30, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of BGB-A445 alone and in combination with tislelizumab in participants with advanced solid tumors; and to determine the maximum tolerated dose(s) (MTD) or maximum administered dose(s) (MAD) and recommended Phase 2 doses (RP2D) of BGB-A445 alone and in combination with tislelizumab.

NCT ID: NCT02822495 No longer available - Clinical trials for Stem Cell Transplant Complications

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Start date: n/a
Phase:
Study type: Expanded Access

The primary objective of this protocol is to provide expanded access to tabelecleucel to participants with Epstein-Barr virus-associated diseases and malignancies for whom there are no other appropriate therapeutic options, and who are not eligible to enroll in clinical studies designed to support the development and registration of tabelecleucel.